Leap Therapeutics Inc (LPTX)
2.88
-0.12
(-3.84%)
USD |
NASDAQ |
Nov 14, 16:00
2.95
+0.07
(+2.43%)
After-Hours: 18:21
Leap Therapeutics Shareholders Equity (Quarterly): 65.79M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 65.79M |
| March 31, 2024 | 47.37M |
| December 31, 2023 | 60.14M |
| September 30, 2023 | 72.01M |
| June 30, 2023 | 84.06M |
| March 31, 2023 | 28.33M |
| December 31, 2022 | 58.87M |
| September 30, 2022 | 70.07M |
| June 30, 2022 | 83.32M |
| March 31, 2022 | 98.56M |
| December 31, 2021 | 107.89M |
| September 30, 2021 | 116.82M |
| June 30, 2021 | 29.88M |
| March 31, 2021 | 38.38M |
| December 31, 2020 | 46.65M |
| September 30, 2020 | 53.14M |
| June 30, 2020 | 59.73M |
| March 31, 2020 | 17.96M |
| December 31, 2019 | -1.749M |
| September 30, 2019 | 5.562M |
| June 30, 2019 | 10.94M |
| Date | Value |
|---|---|
| March 31, 2019 | 17.06M |
| December 31, 2018 | 9.175M |
| September 30, 2018 | 6.628M |
| June 30, 2018 | 12.14M |
| March 31, 2018 | 16.13M |
| December 31, 2017 | 11.12M |
| September 30, 2017 | 11.58M |
| June 30, 2017 | 18.35M |
| March 31, 2017 | 24.17M |
| December 31, 2016 | -100.23M |
| June 30, 2016 | 25.05M |
| December 31, 2015 | -70.29M |
| September 30, 2015 | 28.69M |
| June 30, 2015 | 33.91M |
| March 31, 2015 | 39.90M |
| December 31, 2014 | 46.21M |
| September 30, 2014 | 53.38M |
| June 30, 2014 | 11.53M |
| March 31, 2014 | 15.47M |
| December 31, 2013 | 18.77M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-1.749M
Minimum
Dec 2019
116.82M
Maximum
Sep 2021
59.85M
Average
59.73M
Median
Jun 2020
Shareholders Equity (Quarterly) Benchmarks
| AIM ImmunoTech Inc | 6.102M |
| Perspective Therapeutics Inc | 341.00M |
| Protalix BioTherapeutics Inc | 28.58M |
| Electromed Inc | 44.54M |
| Armata Pharmaceuticals Inc | -46.10M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 81.43M |
| Total Liabilities (Quarterly) | 15.64M |